Naltrexona Accord (Naltrexone Hydrochloride)

Naltrexone is a competitive antagonist at mu, kappa and delta opioid receptors. By binding to these receptors without activating them, it blocks both endogenous opioids and external opioid drugs, preventing the usual physiological and psychological responses associated with their use.

The specific dose and dosing schedule of Naltrexona Accord are determined by the prescribing clinician based on the patient’s condition, treatment goals and clinical response. Patients should follow the prescriber’s instructions exactly.

Safety data for naltrexone in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs the possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To request Naltrexona Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Naltrexona Accord contains naltrexone, a long‑acting oral antagonist, whereas drugs like naloxone are short‑acting and typically administered by injection for emergency overdose reversal. Naltrexone is preferred for maintenance therapy in dependence, while naloxone is used for acute reversal.

Store Naltrexona Accord at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Naltrexona Accord is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. The medication should be swallowed whole and not chewed or crushed unless specifically instructed.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis or angioedema, and the emergence of depression or suicidal thoughts. Patients should report any signs of liver dysfunction, rash, swelling, or mood changes to their healthcare provider promptly.

Naltrexona Accord is contraindicated in individuals with a known hypersensitivity to naltrexone or any of its excipients, those currently using opioid analgesics (due to risk of precipitated withdrawal), and patients with severe hepatic impairment without appropriate medical supervision.